EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Daily versus Alternate-Day Iron Supplementation for Pregnant Women with Iron Deficiency Anemia: A Randomized Controlled Trial

Melissa Chu Lam iD, Binny Khandakar, Isaak Heon, Farrah Hussain, Kristina Feldman, Elianna Kaplowitz iD, Jessica R Overbey, Lois Brustman, Barak Rosenn

American Journal of Perinatology · 01.04.2025 · 42 (06) · 699-707

DOI: 10.1055/a-2405-1381 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Perinatology, erschienen am 01.04.2025. Verfasst von Melissa Chu Lam und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Northshore University Hospital, Manhasset, New York. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Ferrous Compounds, Dietary Supplements, Pregnancy Complications, Hematologic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate the most effective regimen to raise hemoglobin (Hb) by comparing alternate-day dosing of iron to daily dosing in pregnant women with iron deficiency anemia. Women with Hb < 11.0 g/dL and ferritin ≤ 25 µg/L between 120/7 and 340/7 weeks' gestation were recruited. A total of 88 patients were randomized using block randomization with 1:1 allocation to receive either 1 tablet of 325 mg ferrous sulfate on consecutive days or 2 tablets every other day. The primary outcome, the change in Hb after 6 weeks of treatment was assessed using an analysis of covariance to adjust for baseline level. Secondary outcomes included change in ferritin, hepcidin, side effects, and compliance. Patients completed a questionnaire to assess for adverse symptoms and adherence was monitored by installing a pill reminder app on smartphones of patients. A total of 88 patients were consented. The daily iron group had a greater proportion of nulliparous women (40 vs. 7%). Most patients (98%) had mild anemia (Hb: 9–10.9 g/dL) at recruitment, with a median gestational age of 28.1 weeks (interquartile range [IQR]: 25.6, 30.9) and median duration of treatment of 42 days (IQR: 35, 45). At 6 weeks, the daily iron group had a mean increase in Hb of 0.8 ± 0.9 g/dL, whereas the alternate-day iron group had a mean increase of 0.5 ± 1.0 g/dL (baseline adjusted difference of means: −0.3 [95% confidence interval: −0.7, 0.1], p = 0.15). Frequency of adverse effects attributable to iron were similar between groups. Patient self-reported compliance to treatment was also similar between groups. Among those that used the app, compliance was higher among the daily group compared with the alternate daily group (median: 95.5% [IQR: 75, 100] vs. 85% [IQR: 40, 92]), although this difference was not statistically significant (p = 0.07). This trial suggests that there are no significant differences between alternate-day iron supplementation and daily iron supplementation for treating iron deficiency anemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Iron-DeficiencyFerrous CompoundsDietary SupplementsPregnancy Complications, HematologicHumansFemalePregnancyAdultHemoglobinsFerritinsDrug Administration ScheduleYoung Adult

Substanzen

Ferrous Compoundsferrous sulfateHemoglobinsFerritins

Autor:innen und Institutionen

  • Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Northshore University Hospital, Manhasset, New York.
  • Department of Pathology, Mount Sinai West, New York, New York.
  • Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Mount Sinai West Hospital, New York, New York.
  • Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Division of Maternal Fetal Medicine, Jersey City Medical Center, Jersey City, New Jersey.

ORCID-Profile: Melissa Chu Lam, Elianna Kaplowitz

Zitieren

APA

Lam, M. C., Khandakar, B., Heon, I., Hussain, F., Feldman, K., Kaplowitz, E., Overbey, J. R., Brustman, L., & Rosenn, B. (2025). Daily versus Alternate-Day Iron Supplementation for Pregnant Women with Iron Deficiency Anemia: A Randomized Controlled Trial. American Journal of Perinatology, 42(06), 699-707. https://doi.org/10.1055/a-2405-1381

Vancouver

Lam MC, Khandakar B, Heon I, Hussain F, Feldman K, Kaplowitz E, et al. Daily versus Alternate-Day Iron Supplementation for Pregnant Women with Iron Deficiency Anemia: A Randomized Controlled Trial. American Journal of Perinatology. 2025;42(06):699-707. doi:10.1055/a-2405-1381

BibTeX
@article{Lam2025,
  author = {Lam, Melissa Chu and Khandakar, Binny and Heon, Isaak and Hussain, Farrah and Feldman, Kristina and Kaplowitz, Elianna and Overbey, Jessica R and Brustman, Lois and Rosenn, Barak},
  title = {Daily versus Alternate-Day Iron Supplementation for Pregnant Women with Iron Deficiency Anemia: A Randomized Controlled Trial},
  journal = {American Journal of Perinatology},
  year = {2025},
  volume = {42},
  number = {06},
  pages = {699--707},
  doi = {10.1055/a-2405-1381}
}
Kostenlos starten →